Ligand id: 7049

Name: teduglutide

1. Blonski W, Buchner AM, Aberra F, Lichtenstein G. (2013)
Teduglutide in Crohn's disease.
Expert Opin Biol Ther, 13 (8): 1207-14. [PMID:23834252]
2. Jeppesen PB. (2012)
Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome.
Therap Adv Gastroenterol, 5 (3): 159-71. [PMID:22570676]
3. Kochar B, Long MD, Shelton E, Young L, Farraye FA, Yajnik V, Herfarth H. (2017)
Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
J. Clin. Gastroenterol., 51 (6): 508-511. [PMID:27433811]
4. McKeage K. (2015)
Teduglutide: a guide to its use in short bowel syndrome.
Clin Drug Investig, 35 (5): 335-40. [PMID:25859983]
5. Yazbeck R. (2010)
Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.
Curr. Opin. Mol. Ther., 12 (6): 798-809. [PMID:21154171]